Ultragenyx Pharmaceutical Inc. buy melinda
Start price
31.08.17
/
50%
€50.68
Target price
26.12.17
€63.14
Performance (%)
-14.69%
End price
26.12.17
€43.23
Summary
This prediction ended on 26.12.17 with a price of €43.23. The price of Ultragenyx Pharmaceutical Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.69%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 22.619% | 22.619% | -51.869% | -54.222% |
| iShares Core DAX® | 2.659% | 4.844% | 23.110% | 68.731% |
| iShares Nasdaq 100 | 0.916% | -0.554% | 6.985% | 113.533% |
| iShares Nikkei 225® | 2.426% | 1.598% | 15.780% | 50.934% |
| iShares S&P 500 | 1.230% | 1.039% | 4.695% | 68.205% |
Comments by melinda for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
(Vom Mitglied beendet)
Stopped prediction by melinda for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€73.50
25.08.20
25.08.20
€77.00
04.11.21
04.11.21
1.36%
05.11.21
05.11.21
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€57.91
23.06.17
23.06.17
€76.67
20.07.17
20.07.17
8.44%
20.07.17
20.07.17
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€64.20
23.06.17
23.06.17
€85.00
20.07.17
20.07.17
8.44%
20.07.17
20.07.17
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€68.19
05.01.17
05.01.17
€76.67
27.02.17
27.02.17
12.65%
27.02.17
27.02.17